Nitric Oxide Donors and Cardiovascular Agents Modulating the Bioactivity of Nitric Oxide

DOI Web Site 被引用文献6件
  • Louis J. Ignarro
    From the Nitric Oxide Research Group (L.J.I.), Molecular and Medical Pharmacology, Center for the Health Sciences, University of California, Los Angeles; the Department of Medicine (C.N.), Federico II University of Naples, Naples, Italy; the Department of Medicine (C.N.), University of California, San Diego; and the Evans Department of Medicine (J.L.), Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Mass.
  • Claudio Napoli
    From the Nitric Oxide Research Group (L.J.I.), Molecular and Medical Pharmacology, Center for the Health Sciences, University of California, Los Angeles; the Department of Medicine (C.N.), Federico II University of Naples, Naples, Italy; the Department of Medicine (C.N.), University of California, San Diego; and the Evans Department of Medicine (J.L.), Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Mass.
  • Joseph Loscalzo
    From the Nitric Oxide Research Group (L.J.I.), Molecular and Medical Pharmacology, Center for the Health Sciences, University of California, Los Angeles; the Department of Medicine (C.N.), Federico II University of Naples, Naples, Italy; the Department of Medicine (C.N.), University of California, San Diego; and the Evans Department of Medicine (J.L.), Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Mass.

書誌事項

タイトル別名
  • An Overview

この論文をさがす

抄録

<jats:p>Nitric oxide (NO) mediates multiple physiological and pathophysiological processes in the cardiovascular system. Pharmacological compounds that release NO have been useful tools for evaluating the pivotal role of NO in cardiovascular physiology and therapeutics. These agents constitute two broad classes of compounds, those that release NO or one of its redox congeners spontaneously and those that require enzymatic metabolism to generate NO. In addition, several commonly used cardiovascular drugs exert their beneficial action, in part, by modulating the NO pathway. Here, we review these classes of agents, summarizing their fundamental chemistry and pharmacology, and provide an overview of their cardiovascular mechanisms of action.</jats:p>

収録刊行物

  • Circulation Research

    Circulation Research 90 (1), 21-28, 2002-01-11

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (6)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ